Researchers estimated the lifetime risk of gastrointestinal cancer and associated mortality.
Boehringer plans to again increase R&D spending; Valneva, Pfizer to advance Lyme vaccine candidate
Plus, news about OPKO, HealthCare Royalty, Inventiva, Exscientia and GT Apeiron: Boehringer Ingelheim ups its R&D budget: Back in April, the company said it …